Platelets are behind the cognitive benefits of young blood, exercise and the longevity hormone klotho
FDA Approves First Phosphate Absorption Inhibitor for CKD
The FDA approved the first-in-class phosphate absorption inhibitor tenapanor (Xphozah) to reduce serum phosphorus in chronic kidney disease (CKD) patients on dialysis, developer Ardelyx announced